News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Roche Beats Recession in First Quarter
April 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH (Reuters) - Swiss drugmaker Roche Holding brushed off the downturn in the first quarter, posting a 7 percent rise in sales led by cancer medicine Avastin, and sounded a confident note for the full year.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
Roche
MORE ON THIS TOPIC
Series A
New biotech cAMPfield emerges with $180M to reshape IBD treatment
June 18, 2026
·
2 min read
·
Gabrielle Masson
IPO tracker
Cardio biotech Kardigan binds off $400M upsized IPO
June 18, 2026
·
16 min read
·
Editorial Team
Manufacturing
Moderna mulls deals to rescue German BioNTech plants from closure: report
June 18, 2026
·
2 min read
·
Nick Paul Taylor
Job Trends
Ones to watch: 4 biotechs with recent Series B raises (that are also hiring)
June 18, 2026
·
4 min read
·
Angela Gabriel
